Putnam BioRevolution ETF (SYNB)

Assets	$5.33M
Expense Ratio	0.71%
PE Ratio	26.03
Shares Out	175,000
Dividend (ttm)	$0.21
Dividend Yield	0.70%
Ex-Dividend Date	Dec 5, 2024
Payout Ratio	18.30%
1-Year Return	+7.08%

Volume	267
Open	30.61
Previous Close	30.40
Day's Range	30.42 - 30.61
52-Week Low	28.24
52-Week High	33.23
Beta	1.00
Holdings	35
Inception Date	Sep 29, 2022

About SYNB

Fund Home Page

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: SYNB
• ETF Provider: Putnam

Top 10 Holdings

51.00% of assets

Name	Symbol	Weight
Thermo Fisher Scientific Inc.	TMO	6.68%
Danaher Corporation	DHR	6.29%
Bio-Rad Laboratories, Inc.	BIO	6.13%
NVIDIA Corporation	NVDA	6.01%
AbbVie Inc.	ABBV	5.11%
Corteva, Inc.	CTVA	4.79%
Novonesis A/S	NVZMY	4.71%
AstraZeneca PLC	AZN	3.80%
Eli Lilly and Company	LLY	3.75%
Alphabet Inc.	GOOGL	3.73%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 5, 2024	$0.214	n/a
Dec 6, 2023	$0.021	Dec 11, 2023